These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

130 related items for PubMed ID: 2665352

  • 21. Induction of lepromin positivity by a candidate anti-leprosy vaccine Mycobacterium w in lepromin negative healthy contacts of multibacillary leprosy patients.
    Kar HK, Sharma AK, Misra RS, Zaheer SA, Mukherjee A, Mukherjee R, Beena KR, Kaur H, Nair SK, Talwar GP.
    Indian J Lepr; 1992; 64(4):495-500. PubMed ID: 1308525
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Adoptive transfer of tolerance induced by ICRC bacilli against Mycobacterium leprae in mice.
    Jeevan A, Bapat CV, Deo MG.
    Int J Lepr Other Mycobact Dis; 1986 Sep; 54(3):437-45. PubMed ID: 3528346
    [Abstract] [Full Text] [Related]

  • 25. Regional lymphadenitis following antileprosy vaccine BCG with killed Mycobacterium leprae.
    De Britto RL, Ramanathan VD, Gupte MD.
    Int J Lepr Other Mycobact Dis; 1997 Mar; 65(1):12-9. PubMed ID: 9207749
    [Abstract] [Full Text] [Related]

  • 26. Sensitization potential and reactogenicity of varying doses of BCG plus killed Mycobacterium leprae: an extended study.
    Gupte MD, Vallishayee RS, De Britto LJ, Anantharaman DS.
    Int J Lepr Other Mycobact Dis; 1993 Dec; 61(4):563-70. PubMed ID: 8151187
    [Abstract] [Full Text] [Related]

  • 27. Immunotherapy of lepromin-negative borderline leprosy patients with low-dose Convit vaccine as an adjunct to multidrug therapy; a six-year follow-up study in Calcutta.
    Chaudhury S, Hajra SK, Mukerjee A, Saha B, Majumdar V, Chattapadhya D, Saha K.
    Int J Lepr Other Mycobact Dis; 1997 Mar; 65(1):56-62. PubMed ID: 9207754
    [Abstract] [Full Text] [Related]

  • 28. Anti-leprosy vaccines--field trials and future prospects.
    Deo MG.
    Indian J Lepr; 1984 Mar; 56(4):764-75. PubMed ID: 6442720
    [Abstract] [Full Text] [Related]

  • 29. Leprosy vaccine--a puzzle.
    Job CK.
    Lepr India; 1983 Jan; 55(1):1-7. PubMed ID: 6348409
    [No Abstract] [Full Text] [Related]

  • 30. ICRC vaccine-induced changes in M. leprae-specific cell-mediated immunity in langur (Presbytis entellus) monkeys.
    Chirmule NB, Deo MG, Sirodkar MV, Deshmukh R, Chanderkar NG.
    Int J Lepr Other Mycobact Dis; 1986 Mar; 54(1):57-62. PubMed ID: 3519805
    [Abstract] [Full Text] [Related]

  • 31. India carries out large-scale tests of anti-leprosy vaccine.
    Jayaraman KS.
    Nature; 1986 Mar; 328(6132):660. PubMed ID: 3302728
    [No Abstract] [Full Text] [Related]

  • 32. ELISA & lepromin skin tests in household contacts of leprosy patients.
    Dhandayuthapani S, Anandan D, Bhatia VN.
    Indian J Med Res; 1990 Nov; 91():431-6. PubMed ID: 2091988
    [Abstract] [Full Text] [Related]

  • 33. Vaccine trials against leprosy.
    Gupte MD.
    Int J Lepr Other Mycobact Dis; 1998 Dec; 66(4):587-9. PubMed ID: 10347583
    [No Abstract] [Full Text] [Related]

  • 34. BCG immunotherapy as an adjunct to chemotherapy in BL-lL patients--its effect on clinical regression, reaction severity, nerve function, lepromin conversion, bacterial/antigen clearance and 'persister' M. leprae.
    Shetty VP, Mistry NF, Wakade AV, Ghate SD, Capadia GD, Pai VV.
    Lepr Rev; 2013 Mar; 84(1):23-40. PubMed ID: 23741880
    [Abstract] [Full Text] [Related]

  • 35. Randomised controlled trial of single BCG, repeated BCG, or combined BCG and killed Mycobacterium leprae vaccine for prevention of leprosy and tuberculosis in Malawi. Karonga Prevention Trial Group.
    Lancet; 1996 Jul 06; 348(9019):17-24. PubMed ID: 8691924
    [Abstract] [Full Text] [Related]

  • 36. Under-explored experimental topics related to integral mycobacterial vaccines for leprosy.
    Gormus BJ, Meyers WM.
    Expert Rev Vaccines; 2003 Dec 06; 2(6):791-804. PubMed ID: 14711362
    [Abstract] [Full Text] [Related]

  • 37. Response of Mycobacterium habana vaccine in patients with lepromatous leprosy and their household contacts. A pilot clinical study.
    Wakhlu A, Gaur SP, Kaushal GP, Misra A, Asthana P, Sircar AR.
    Lepr Rev; 2001 Jun 06; 72(2):179-91. PubMed ID: 11495449
    [Abstract] [Full Text] [Related]

  • 38. IgM antibodies to native phenolic glycolipid-I in contacts of leprosy patients in Venezuela: epidemiological observations and a prospective study of the risk of leprosy.
    Ulrich M, Smith PG, Sampson C, Zuniga M, Centeno M, Garcia V, Manrique X, Salgado A, Convit J.
    Int J Lepr Other Mycobact Dis; 1991 Sep 06; 59(3):405-15. PubMed ID: 1890364
    [Abstract] [Full Text] [Related]

  • 39. Delayed-type hypersensitivity, mycobacterial vaccines and protective immunity.
    Fine PE, Sterne JA, Pönnighaus JM, Rees RJ.
    Lancet; 1994 Nov 05; 344(8932):1245-9. PubMed ID: 7967984
    [Abstract] [Full Text] [Related]

  • 40. BCG vaccination in leprosy.
    Price JE.
    Int J Lepr Other Mycobact Dis; 1982 Jun 05; 50(2):205-12. PubMed ID: 6749707
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.